# Specific Forms of Substance Misuse Increase Stroke Risk – MPR – eMPR.com > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-use-disorder-stroke-risk/ > **Published:** 2026-03-19T17:29:47-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:05:02-04:00 > **Clinical Summary:** Explore how cannabis use disorder stroke risk impacts younger patients and why clinicians should screen for this in stroke assessments. --- ✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyMental HealthSafetyResearch Why This Matters Clinicians should screen for [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) in patients presenting with stroke, particularly younger patients where traditional cardiovascular risk factors may be absent, as the evidence now links [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) disorder to both any stroke and large artery stroke subtypes. Understanding this association enables more comprehensive risk stratification and may inform conversations about [substance use](https://cedclinic.com/stroke-risk-assessment-substance-use/) cessation as a modifiable stroke prevention strategy. Patients with cannabis use disorder should be counseled about stroke risk alongside other substance-related health consequences to support informed decision-making about continued use. Clinical Summary A [systematic review](https://cedclinic.com/cannabinoid-safety-efficacy-mental-health-study/) and meta-analysis found that cannabis use disorder is associated with increased risk of any stroke and specifically large artery strokes, though the evidence showed some heterogeneity across studies and potential small-study effects. This finding is particularly relevant for clinicians assessing cardiovascular risk in patients with cannabis use disorder, as stroke represents a serious vascular complication that may warrant preventive interventions or closer monitoring. The mechanistic link likely involves cannabis-induced thrombotic and vasospastic effects, though the clinical relationship remains incompletely understood and warrants further investigation. Physicians should incorporate cannabis use disorder status into their stroke [risk assessment](https://cedclinic.com/ethical-legal-dilemmas-cannabis-use/) algorithms and consider discussing this cardiovascular risk with patients who use cannabis regularly or meet criteria for use disorder. For patients with established cannabis use disorder, especially those with additional stroke risk factors, clinicians should counsel on smoking cessation and consider standard stroke prevention strategies while remaining alert to potential cannabis-related mechanisms of vascular injury. Dr. Caplan’s Take “What we’re seeing in the stroke literature is that cannabis use disorder, not occasional use, carries a measurable vascular risk that clinicians need to screen for actively in their patient histories, particularly in younger stroke patients where we might otherwise miss the connection.” Clinical Perspective The association between cannabis use disorder and increased stroke risk reported in this meta-analysis warrants clinical attention, particularly given the growing prevalence of cannabis use and potential normalization of its safety profile among patients. However, clinicians should note significant heterogeneity in the cannabis findings and evidence of small-study effects, which suggest the true magnitude of risk remains uncertain and may be inflated by publication bias. The causal mechanisms linking cannabis to stroke are not fully established—confounding factors such as concurrent tobacco use, cardiovascular comorbidities, and the effects of other substances are difficult to fully disentangle in observational studies. When taking a substance use history, providers should specifically inquire about cannabis use patterns and frequency in patients presenting with stroke or those with multiple vascular risk factors, and counsel patients with existing stroke risk factors or personal/family history of stroke about the potential cerebrovascular implications of cannabis use disorder. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/medical-illness/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Specific+Forms+of+Substance+Misuse+Increase+Stroke+Risk+-+MPR+-+eMPR.com+%40drcaplan&url=https%3A%2F%2Fwww.empr.com%2Fnews%2Fspecific-forms-of-substance-misuse-increase-stroke-risk%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.empr.com%2Fnews%2Fspecific-forms-of-substance-misuse-increase-stroke-risk%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Specific+Forms+of+Substance+Misuse+Increase+Stroke+Risk+-+MPR+-+eMPR.com+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.empr.com%2Fnews%2Fspecific-forms-of-substance-misuse-increase-stroke-risk%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [CED Digest: 405 Items — March 12, 2026](https://cedclinic.com/alabama-medical-cannabis-sales-2026-spring-launch/) 📰 Source: [https://www.empr.com/news/specific-forms-of-substance-misuse-increase-stroke-risk/](https://www.empr.com/news/specific-forms-of-substance-misuse-increase-stroke-risk/) Further Reading Evidence Watch[The Brain Science Behind the Munchies – Nautilus Magazine](https://cedclinic.com/cannabis-appetite-stimulation-neuroscience/) Evidence WatchIGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial Research Digest[Research Digest: 20 Recent Studies – March 18, 2026](https://cedclinic.com/research-digest-recent-studies-march-2026/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Specific Forms of Substance Misuse Increase Stroke Risk – Neurology Advisor](https://cedclinic.com/stroke-risk-cannabis-use-patterns-neurology-advisor/) Detailed analysis of how various substance misuse forms contribute to stroke risk, with clinical recommendations. [Read More](https://cedclinic.com/stroke-risk-cannabis-use-patterns-neurology-advisor/) [Recreational drugs can more than double risk of stroke, study suggests – The Guardian](https://cedclinic.com/cannabis-stroke-risk-clinical-evidence-stroke-prevention/) Study findings on the elevated stroke risk associated with recreational drug use, including cannabis. [Explore Study](https://cedclinic.com/cannabis-stroke-risk-clinical-evidence-stroke-prevention/) [Drug Use May Double Stroke Risk: Study Analysing 100 Million People Warns | GRAVITAS](https://cedclinic.com/recreational-drug-stroke-risk-study/) Large-scale study highlighting the doubled stroke risk linked to drug use, emphasizing clinical implications. [Learn More](https://cedclinic.com/recreational-drug-stroke-risk-study/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).